Literature DB >> 21093356

Persistence of varicella-zoster virus viraemia in patients with herpes zoster.

M L Quinlivan1, K L Ayres, P J Kelly, S P Parker, F T Scott, R W Johnson, C Maple, J Breuer.   

Abstract

BACKGROUND: Herpes zoster is caused by the reactivation of varicella-zoster virus from sensory neurons. The commonest complication following zoster is chronic pain termed post herpetic neuralgia.
OBJECTIVES: To investigate the dynamics of VZV viraemia and viral load following the resolution of zoster and its relationship to PHN development. STUDY
DESIGN: Blood samples were collected at baseline, 1 month, 3 months and 6 month from a prospective study of 63 patients with active zoster. Quantification of VZV DNA in whole blood was performed using a real-time PCR assay.
RESULTS: During acute zoster, all patients had detectable VZV DNA in their blood. VZV DNA remained detectable in the blood of 91% of patients at 6 months although levels declined significantly (p<0.0001). A history of prodromal symptoms (p=0.005) and severity of pain at baseline (p=0.038) as well as taking antivirals (p=0.046) and being immunocompromised (p=0.043) were associated, with longer time to recovery from PHN. Viral DNA loads were consistently higher in patients with risk factors for PHN and higher viral DNA loads over time were associated with longer time to recovery (p=0.058 overall and 0.038 in immunocompetent).
CONCLUSIONS: Based on these observations we hypothesise that VZV replication persists following acute shingles and that higher viral DNA loads contribute to the risk factors for PHN.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093356     DOI: 10.1016/j.jcv.2010.10.014

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  12 in total

1.  Varicella zoster virus transmission in the vaccine era: unmasking the role of herpes zoster.

Authors:  Karen C Bloch; James G Johnson
Journal:  J Infect Dis       Date:  2012-03-27       Impact factor: 5.226

2.  Cytomegalovirus seropositivity is associated with herpes zoster.

Authors:  Benson Ogunjimi; Niel Hens; Richard Pebody; Hilde Jansens; Holly Seale; Mark Quinlivan; Heidi Theeten; Herman Goossens; Judy Breuer; Philippe Beutels
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

4.  Honeysuckle-derived microRNA2911 directly inhibits varicella-zoster virus replication by targeting IE62 gene.

Authors:  Ying Huang; Huabo Liu; Xinlei Sun; Meng Ding; Gaojian Tao; Xihan Li
Journal:  J Neurovirol       Date:  2019-05-28       Impact factor: 2.643

5.  Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.

Authors:  Naoki Inoue; Misato Matsushita; Yoshiko Fukui; Souichi Yamada; Mihoko Tsuda; Chizuka Higashi; Keiko Kaneko; Hideki Hasegawa; Toyofumi Yamaguchi
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

Review 6.  Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?

Authors:  Anne A Gershon
Journal:  J Infect       Date:  2017-06       Impact factor: 6.072

7.  Multicenter Evaluation of the Simplexa VZV Direct Assay for Detection of Varicella-Zoster Virus in Cerebrospinal Fluid and Lesion-Swab Specimens.

Authors:  P Pancholi; R F Relich; S Chandrasekaran; J J Dunn; P A Granato; A T Harrington; G T Hansen; N A Ledeboer; Q Li; M D Sims; T S Uphoff; W Greene; S Young; N Dhiman
Journal:  J Clin Microbiol       Date:  2022-03-14       Impact factor: 11.677

Review 8.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

9.  Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK.

Authors:  Judith Breuer; Maud Pacou; Aline Gauthier; Martin M Brown
Journal:  Neurology       Date:  2014-01-02       Impact factor: 9.910

10.  Varicella-zoster viruses associated with post-herpetic neuralgia induce sodium current density increases in the ND7-23 Nav-1.8 neuroblastoma cell line.

Authors:  Peter G E Kennedy; Paul Montague; Fiona Scott; Esther Grinfeld; G H Ashrafi; Judith Breuer; Edward G Rowan
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.